Therapeutic angiogenesis following intramuscular gene transfer of vascularendothelial growth factor 121 in a dog model of hindlimb ischemia

Electronic Journal of Biotechnology

Volumn 6, Issue 3, 2003, Pages 45-59

  Ojalvo, Ariana G ^a   Seralena, Alina ^a   Vázquez, Raysa ^a   Montequín, José F ^b   Vispo, Nelson S ^a   Silva, Ricardo ^a   Aldama, Alfredo ^b   Puchades, Yaquelin ^a   Sorell, Luis T ^b   Lopez Saura, Pedro ^a   Alfonso, María A ^b   Simón, Rafael ^b   Alí, Alfonso ^a   Seuc, Armando ^b   Herrera, Luis ^a  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^b Pathology Department   (Cuba)

Author keywords

Collateral development; Gene therapy; Naked plasmid DNA; Peripheral vascular disease; Revascularization

Indexed keywords

AMINO ACID; PLASMID DNA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 121;

ANGIOGENESIS; ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD EXAMINATION; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DOG; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; IN VIVO STUDY; LIMB ISCHEMIA; MOLECULAR CLONING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; TISSUE PERFUSION; VASOMOTOR REFLEX;

ANIMALIA; CANIS FAMILIARIS;

EID: 3042698024     PISSN: 07173458     EISSN: None     Source Type: Journal    
DOI: 10.2225/vol6-issue3-fulltext-2     Document Type: Article

References (51)

1. BAFFOUR, R.; BERMAN, J.; GARB, J.L.; RHEE, S.W.; KAUFMAN, J. and FRIEDMANN, P. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. Journal of Vascular Surgery, August 1992, vol. 16, no. 2, p. 181-191.
2. BAUMGARTNER, I.; PIECZEK, A.; MANOR, O.; BLAIR, R.; KEARNEY, M.; WALSH, K. and ISNER, J.M. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation, March 1998, vol. 97, no. 12, p. 1114-1123.
3. BAUTERS, C.; ASAHARA, T.; ZHENG, L.P.; TAKESHITA, S.; BUNTING, S.; FERRARA, N.; SYMES, J.F. and ISNER J.M. Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. Journal of Vascular Surgery, February 1995, vol. 21, no. 2, p. 314-324.
4. BENELLI, R. and ALBINI, A. In vitro models of angiogenesis: the use of Matrigel. International Journal of Biological Markers, October-December 1999, vol. 14, no. 4, p. 243-246.
5. BOULTON, M.; FOREMAN, D.; WILLIAMS, G. and MCLEOD, D.VEGF localization in diabetic retinopathy. British Journal of Ophthalmology, May 1998, vol. 82, no. 5, p. 561-568.
6. BROGI, E.; SCHATTEMAN, G.; WU, T.; KIM, E.A.; VARTICOVSKI, L.; KEYT, B. and ISNER, J.M. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. Journal of Clinical Investigation, January 1996, vol. 97, no. 2, p. 469-476.
7. BURLINGAME, R.W.; BOEY, M.L.; STARKEBAUM, G. and RUBIN, R.L. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. Journal of Clinical Investigation, July 1994, vol. 94, no. 1, p. 184-192.
8. CREAGER, M.A. Medical management of peripheral arterial disease. Cardiology Reviews, July-August 2001, vol. 9, no. 4, p. 238-245.
9. DANKO, I. and WOLFF, J.A. Direct gene transfer into muscle. Vaccine, December 1994, vol. 12, no. 16, p. 1499-1502.
10. DORMANDY, J.; HEECK, L. and VIG, S. Major amputations: clinical patterns and predictors. Seminars in Vascular Surgery, June 1999, vol. 12, no. 2, p. 154-161.
11. DULAK, J.; JOZKOWICZ, A.; RATAJSKA, A.; SZUBA, A.; COOKE, J.P. and DEMBINSKA-KIEC, A. Vascular endothelial growth factor is efficiently synthesized in spite of low transfection efficiency of pSG5VEGF plasmids in vascular smooth muscle cells. Vascular Medicine, 2000, vol. 5, no. 1, p. 33-40.
12. EPPLER, S.M.; MCCLUSKEY, E.R.; HENRY, T.D.; SIMONS, M.; GIORDANO, F.J. and ZIOINCHECK, T.F. Unique kinetics and hemodynamics of vascular endothelial growth factor (rhVEGF) following intracoronary and intravenous infusion in humans [Abstract]. Journal of the American College of Cardiology, 2000, vol. 35, p. 73A.
13. EPSTEIN, S.E.; FUCHS, S.; ZHOU, Y.F.; BAFFOUR, R. and KORNOWSKI, R. Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards. Cardiovascular Research, February 2001, vol. 49, no. 3, p. 532-542.
14. GARDNER, A.W. and KILLEWICH, L.A. Lack of functional benefits following infrainguinal bypass in peripheral arterial occlusive disease patients. Vascular Medicine, 2001, vol. 6, no. 1, p. 9-14.
15. GOWDAK, L.H.; POLIAKOVA, L.; WANG, X.; KOVESDI, I.; FISHBEIN, K.W.; ZACHEO, A.; PALUMBO, R.; STRAINO, S.; EMANUELI, C.; MARROCCO-TRISCHITTA, M.; LAKATTA, E.G.; ANVERSA, P.; SPENCER, R.G.; TALAN, M. and CAPOGROSSI, M.C. Adenovirus-mediated VEGF(121) gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia. Circulation, August 2000, vol. 102, no. 5, p. 565-571.
16. HARIAWALA, M.D.; HOROWITZ, J.R.; ESAKOF, D.; SHERIFF, D.D.; WALTER, D.H.; KEYT, B.; ISNER, J.M. and SYMES J.F. VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. Journal of Surgical Research, June 1996, vol. 63, no. 1, p. 77-82.
17. HERRERA, A.M.; RODRÍGUEZ, E.G.; HERNÁNDEZ, T.; SÁNDEZ, B. and DUARTE, C.A. A family of compact plasmid vectors for DNA immunization in humans. Biochemical and Biophysical Research Communications, December 2000, vol. 279, no. 2, p. 548-551.
18. HOROWITZ, J.R.; RIVARD, A.; VAN DER ZEE, R.; HARIAWALA, M.; SHERIFF, D.D.; ESAKOF, D.D.; CHAUDHRY, G.M.; SYMES, J.F. and ISNER, J.M. Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium. Arteriosclerosis and Thrombosis Vascular Biology, November 1997, vol. 17, no. 11, p. 2793-2800.
19. HOUCK, K.A.; LEUNG, D.W.; ROWLAND, A.M.; WINER, J. and FERRARA, N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. Journal of Biological Chemistry, December 1992, vol. 267, no. 36, p. 26031-26037.
20. ISNER, J.M.; PIECZEK, A.; SCHAINFELD, R.; BLAIR, R.; HALEY, L.; ASAHARA, T.; ROSENFIELD, K.; RAZVI, S.; WALSH, K. and SYMES, J.F. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet, August 1996, vol. 348, no. 9024, p. 370-374.
21. ISNER, J.M.; BAUMGARTNER, I.; RAUH, G.; SCHAINFELD, R.; BLAIR, R.; MANOR, O.; RAZVI, S. and SYMES, J.F. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. Journal of Vascular Surgery, December 1998, vol. 28, no. 6, p. 964-973.
22. LAHIJANI, R.; HULLEY, G.; SORIANO, G.; HORN, N.A. and MARQUET, M. High-yield production of pBR322-derived plasmids intended for human gene therapy by employing a temperature-controllable point mutation. Human Gene Therapy, October 1996, vol. 7, no. 16, p. 1971-1980.
23. LEDLEY, F.D. Nonviral gene therapy: the promise of genes as pharmaceutical products. Human Gene Therapy, September 1995, vol. 6, no. 9, p. 1129-1144.
24. LEE, L.Y.; PATEL, S.R.; HACKETT, N.R.; MACK, C.A.; POLCE, D.R.; EL-SAWY, T.; HACHAMOVITCH, R.; ZANZONICO, P.; SANBORN, T.A.; PARIKH, M.; ISOM, O.W.; CRYSTAL, R.G. and ROSENGART, T.K. Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121. Annals of Thoracic Surgery, January 2000, vol. 69, no. 1, p. 14-23.
25. LEUNG, D.W.; CACHIANES, G.; KUANG, W.J.; GOEDDEL, D.V. and FERRARA, N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science, December 1989, vol. 246, no. 4935, p. 1306-1309.
26. LOPEZ, J.J.; LAHAM, R.J.; STAMLER, A.; PEARLMAN, J.D.; BUNTING, S.; KAPLAN, A.; CARROZZA, J.P.; SELLKE, F.W. and SIMONS, M. VEGF administration in chronic myocardial ischemia in pigs. Cardiovascular Research, November 1998, vol. 40, no. 2, p. 272-281.
27. LOSORDO, D.W.; PICKERING, J.G.; TAKESHITA, S.; LECLERC, G.; GAL, D.; WEIR, L.; KEARNEY, M.; JEKANOWSKI, J. and ISNER, J.M. Use of the rabbit ear artery to serially assess foreign protein secretion after site-specific arterial gene transfer in vivo. Evidence that anatomic identification of successful gene transfer may underestimate the potential magnitude of transgene expression. Circulation, February 1994, vol. 89, no. 2, p. 785-792.
28. NABEL, G.J.; NABEL, E.G.; YANG, Z.Y.; FOX, B.A.; PLAUTZ, G.E.; GAO, X.; HUANG, L.; SHU, S.; GORDON, D. and CHANG, A.E. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proceedings of the National Academy of Sciences of the United States of America, December 1993, vol. 90, no. 23, p. 11307-11311.
29. NEUFELD, G.; COHEN, T.; GENGRINOVITCH, S. and POLTORAK, Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB Journal, January 1999, vol. 13, no. 1, p. 9-22.
30. NIKOL, S. and HUEHNS, T.Y. Preclinical and clinical experience in vascular gene therapy: advantages over conservative/standard therapy. Journal of Invasive Cardiology, April 2001, vol. 13, no. 4, p. 333-338.
31. NORGREN, L. Pharmacotherapy for critical limb ischaemia. Diabetes Metabolism Research Reviews, September-October 2000, vol. 16, Suppl 1, p. S37-S41.
32. PARK, J.E.; KELLER, G.A. and FERRARA, N. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Molecular Biology of the Cell, December 1993, vol. 4, no. 12, p. 1317-1326.
33. PATEL, S.R.; LEE, L.Y.; MACK, C.A.; POLCE, D.R.; EL-SAWY, T.; HACKETT, N.R.; ILERCIL, A.; JONES, E.C.; HAHN, R.T.; ISOM, O.W.; ROSENGART, T.K. and CRYSTAL, R.G. Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121. Human Gene Therapy, May 1999, vol. 10, no. 8, p. 1331-1348.
34. PEPPER, M.S. Extracellular proteolysis and angiogenesis. Thrombosis and Haemostasis, July 2001, vol. 86, no. 1, p. 346-355.
35. PLATE, K.H.; BREIER, G.; WEICH, H.A. and RISAU, W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature, October 1992, vol. 359, no. 6398, p. 845-848.
36. PLOUET, J.; MORO, F.; BERTAGNOLLI, S.; COLDEBOEUF, N.; MAZARGUIL, H.; CLAMENS, S. and BAYARD, F. Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect. Journal of Biological Chemistry, May 1997, vol. 272, no. 20, p. 13390-13396.
37. PU, L.Q.; JACKSON, S.; LACHAPELLE, K.J.; AREKAT, Z.; GRAHAM, A.M.; LISBONA, R.; BRASSARD, R.; CARPENTER, S. and SYMES, J.F. A persistent hindlimb ischemia model in the rabbit. Journal of Investigative Surgery, January-February 1994, vol. 7, no. 1, p. 49-60.
38. RAJAGOPALAN, S.; SHAH, M.; LUCIANO, A.; CRYSTAL, R. and NABEL, E.G. Adenovirus-mediated gene transfer of VEGF(121) improves lower-extremity endothelial function and flow reserve. Circulation, August 2001, vol. 104, no. 7, p. 753-755.
39. RAKUE, H.; NAKAJIMA, H.; KATOH, T.; USUI, M.; AMEMIYA, T.; MIYAGI, M.; HARA, T.; TAMURA, K.; SASAME, A.; NAITO, Y.; NAGAI, Y. and IBUKIYAMA, C. Low-dose basic fibroblast growth factor and vascular endothelial growth factor for angiogenesis in canine acute hindlimb insufficiency. Japanese Circulation Journal, December 1998, vol. 62, no. 12, p. 933-939.
40. ROSENGART, T.K.; LEE, L.Y.; PATEL, S.R.; KLIGFIELD, P.D.; OKIN, P.M.; HACKETT, N.R.; ISOM, O.W. and CRYSTAL, R.G. Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA. Annals of Surgery, October 1999a, vol. 230, no. 4, p. 466-470.
41. ROSENGART, T.K.; LEE, L.Y.; PATEL, S.R.; SANBORN, T.A.; PARIKH, M.; BERGMAN, G.W.; HACHAMOVITCH, R.; SZULC, M.; KLIGFIELD, P.D.; OKIN, P.M.; HAHN, R.T.; DEVEREUX, R.B.; POST, M.R.; HACKETT, N.R.; FOSTER, T.; GRASSO, T.M.; LESSER, M.L.; ISOM, O.W. and CRYSTAL, R.G. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation, August 1999b, vol. 100, no. 5, p. 468-474.
42. SEMENZA, G.L. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends in Molecular Medicine, August 2001, vol. 7, no. 8, p. 345-350.
43. SIEMEISTER, G.; MARTINY-BARON, G. and MARME, D. The pivotal role of VEGF in tumor angiogenesis: molecular facts and therapeutic opportunities. Cancer Metastasis Reviews, June 1998, vol. 17, no. 2, p. 241-248.
44. TAKESHITA, S.; ISSHIKI, T. and SATO, T. Increased expression of direct gene transfer into skeletal muscles observed after acute ischemic injury in rats. Laboratory Investigation, June 1996a, vol. 74, no. 6, p. 1061-1065.
45. TAKESHITA, S.; TSURUMI, Y.; COUFFINAHL, T.; ASAHARA, T.; BAUTERS, C.; SYMES, J.; FERRARA, N. and ISNER, J.M. Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Laboratory Investigation, October 1996b, vol. 75, no. 4, p. 487-501.
46. TAKESHITA, S.; WEIR, L.; CHEN, D.; ZHENG, L.P.; RIESSEN, R.; BAUTERS, C.; SYMES, J.F.; FERRARA, N. and ISNER, J.M. Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. Biochemical and Biophysical Research Communications, October 1996c, vol. 227, no. 2, p. 628-635.
47. TSURUMI, Y.; TAKESHITA, S.; CHEN, D.; KEARNEY, M.; ROSSOW, S.T.; PASSERI, J.; HOROWITZ, J.R.; SYMES, J.F. and ISNER, J.M. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation, December 1996, vol. 94, no. 12, p. 3281-3290.
48. TSURUMI, Y.; KEARNEY, M.; CHEN, D.; SILVER, M.; TAKESHITA, S.; YANG, J.; SYMES, J.F. and ISNER, J.M. Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene. Circulation, November 1997, vol. 96, Suppl 9, p. II-382-II-388.
49. TVEDTEN, H.W. Hematology of the normal dog and cat. Veterinary Clinics of North America Small Animal Practice, May 1981, vol. 11, no. 2, p. 209-217.
50. WALDER, C.E.; ERRETT, C.J.; BUNTING, S.; LINDQUIST, P.; OGEZ, J.R.; HEINSOHN, H.G.; FERRARA, N. and THOMAS, G.R. Vascular endothelial growth factor augments muscle blood flow and function in a rabbit model of chronic hindlimb ischemia. Journal of Cardiovascular Pharmacology, January 1996, vol. 27, no. 1, p. 91-98.
51. YLA-HERTTUALA, S. and ALITALO, K. Gene transfer as a tool to induce therapeutic vascular growth. Nature Medicine, June 2003, vol. 9, no. 6, p. 694-701.